Clinical trial

INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701

NCT05703555

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Tusamitamab ravtansine Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2024-02-16

PhasePHASE2

Conditions

Metastatic Lung Cancerunresolved

Metastatic Breast Cancerunresolved

Metastatic Gastric Cancerunresolved

Interventions

Tusamitamab ravtansineDRUG

Sponsors & collaborators

Erasmus Medical Centerlead sponsor

Sanoficollaborator

Mapped research locations

RotterdamNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05703555 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.